The increasing impact of cancer on worldwide mortality makes the research of novel
chemotherapeutic agents a current and challenging issue. In the recent years, transition …

Ruthenium complex is an important compound group for antitumor drug research and
development. NAMI-A, KP1019, TLD1433 and other ruthenium complexes have entered …

This review focuses on light-activated ruthenium anticancer compounds and the factors that
influence which pathway is favored. Photodynamic therapy (PDT) is favored by π expansion …

Tridentate ligand-coordinated ruthenium (II) polypyridyl complexes with large N–Ru–N bite
angles have been shown to promote ligand field splitting and reduce singlet–triplet state …

Protic ruthenium complexes using the dihydroxybipyridine (dhbp) ligand combined with a
spectator ligand (N, N= bpy, phen, dop, Bphen) have been studied for their potential activity …

Ruthenium complexes bearing protic diimine ligands are cytotoxic to certain cancer cells
upon irradiation with blue light. Previously reported complexes of the type [(N, N) 2Ru (6, 6 …

Nine ruthenium CNC pincer complexes (1–9) were tested for anticancer activity in cell
culture under both dark and light conditions. These complexes included varied CNC pincer …

Photoreactive Ru (II) complexes capable of ejecting ligands have been used extensively for
photocaging applications and for the creation of “photocisplatin” reagents. The incorporation …

There is a clear need to develop photostable chromophores for bioimaging with respect to
the classically utilized green fluorescent dye fluorescein. Along these lines, we utilized a …

We report new ruthenium complexes bearing the lipophilic bathophenanthroline (BPhen)
ligand and dihydroxybipyridine (dhbp) ligands which differ in the placement of the OH …